Related Articles
Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review)
Melatonin ameliorates ANIT‑induced cholestasis by activating Nrf2 through a PI3K/Akt‑dependent pathway in rats
Inhibition of inflammation by SP600125 in cholestatic liver injury is dependent on the administration‑based exposure profile
Identification of potential biomarkers in cholestasis and the therapeutic effect of melatonin by metabolomics, multivariate data and pathway analyses
iTRAQ‑based quantitative proteomics analysis of the hepatoprotective effect of melatonin on ANIT‑induced cholestasis in rats